These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6817737)

  • 1. Elimination of low molecular weight proteins during hemofiltration.
    Röckel A; Gilge U; Liewald A; Heidland A
    Artif Organs; 1982 Aug; 6(3):307-11. PubMed ID: 6817737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes.
    Krämer BK; Pickert A; Hohmann C; Liebich HM; Müller GA; Hablitzel M; Risler T
    Int J Artif Organs; 1992 Jul; 15(7):408-12. PubMed ID: 1516991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis.
    Kabanda A; Jadoul M; Pochet JM; Lauwerys R; van Ypersele de Strihou C; Bernard A
    Kidney Int; 1994 Jun; 45(6):1689-96. PubMed ID: 7933817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sieving and extraction of peptides and proteins during hemofiltration: a systematic review
.
    Baird JS
    Clin Nephrol; 2017 Jun; 87(6):271-277. PubMed ID: 28211786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight protein-permeable cuprammonium rayon haemofilter.
    Menth M; Röckel A; Abdelhamid S; Fiegel P; Walb D
    Nephrol Dial Transplant; 1992; 7(8):844-7. PubMed ID: 1325619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein adsorption by artificial membrane materials under filtration conditions.
    Birk HW; Kistner A; Wizemann V; Schütterle G
    Artif Organs; 1995 May; 19(5):411-5. PubMed ID: 7625919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term performance of hemofilters in continuous hemofiltration.
    Schaeffer J; Olbricht CJ; Koch KM
    Nephron; 1996; 72(2):155-8. PubMed ID: 8684519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes.
    Jørstad S; Smeby LC; Balstad T; Widerøe TE
    Blood Purif; 1988; 6(2):96-105. PubMed ID: 3293621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients.
    Tsuchida K; Minakuchi J
    Contrib Nephrol; 2011; 168():179-187. PubMed ID: 20938139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of plasma proteins during sequential ultrafiltration/dialysis.
    Wichman Z; Pajdak W; Smoleński O; Kopeć J
    Kidney Int; 1985 Sep; 28(3):558-65. PubMed ID: 4068485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of beta 2-microglobulin by a new polyacrylonitrile membrane dialyser: mechanism and physiokinetics.
    Akizawa T; Koshikawa S; Nakazawa R; Yoshida T; Kaneko M; Nitadori Y
    Nephrol Dial Transplant; 1989; 4(5):356-65. PubMed ID: 2505186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four years' experience of long-term hemofiltration in a Swedish center.
    Weiss LG; Danielson BG; Wikström B
    Scand J Urol Nephrol; 1989; 23(3):223-9. PubMed ID: 2678428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of drug removal by continuous hemofiltration.
    Lau AH; Kronfol NO
    Int J Artif Organs; 1994 Jul; 17(7):373-8. PubMed ID: 7806423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow up in chronic hemofiltration.
    Quellhorst E
    Int J Artif Organs; 1983 May; 6(3):115-20. PubMed ID: 6874123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of membrane structure on removal of low molecular weight proteins.
    Takesawa S; Ohashi H; Hidai H; Sakai K
    Artif Organs; 1987 Dec; 11(6):495-7. PubMed ID: 3326562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-microglobulin kinetics during haemofiltration.
    Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
    Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.